Effect of Clopidogrel Pretreatment Before Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Treated With...

Abstract

Clopidogrel pretreatment significantly reduces the incidence of cardiovascular death or ischemic complications both before and after PCI and without a significant increase in major or minor bleeding. These data add further support to the early use of clopidogrel in STEMI and the strategy of routine clopidogrel pretreatment in patients undergoing PCI.

Keywords

MedicineClopidogrelConventional PCIPercutaneous coronary interventionMyocardial infarctionTIMICardiologyInternal medicineStroke (engine)TiclopidineThrombolysis

Affiliated Institutions

Related Publications

Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction

Shlomi Matetzky , Б. С. Шенкман , Victor Guetta +8 more

Background— Although clopidogrel reduces the risk of cardiovascular episodes after coronary events and stenting, a substantial number of incidents continue to occur. Methods and...

2004 Circulation 1352 citations

Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y <sub>12</sub> Antagonist, With Clopidogrel in Percutaneous Coronary Intervention

Stephen D. Wiviott , Elliott M. Antman , Kenneth J. Winters +8 more

Background— Despite the current standard antiplatelet regimen of aspirin and clopidogrel (with or without glycoprotein IIb/IIIa inhibitors) in percutaneous coronary intervention...

2005 Circulation 378 citations

Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome

Keith A.A. Fox , Shamir R. Mehta , Ron J.G. Peters +4 more

Background— Antiplatelet therapy and antithrombin therapy have been demonstrated to reduce the risk of cardiac events in patients presenting with acute coronary syndrome, yet al...

2004 Circulation 831 citations

Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation

Salim Yusuf , Fei-Li Zhao , Shaesta Mehta +4 more

The antiplatelet agent clopidogrel has beneficial effects in patients with acute coronary syndromes without ST-segment elevation. However, the risk of major bleeding is increase...

2001 New England Journal of Medicine 6436 citations

Differential Time Trends of Outcomes and Costs of Care for Acute Myocardial Infarction Hospitalizations by ST Elevation and Type of Intervention in the United States, 2001–2011

Takehiro Sugiyama , Kohei Hasegawa , Yasuki Kobayashi +3 more

Background Little is known whether time trends of in‐hospital mortality and costs of care for acute myocardial infarction ( AMI ) differ by type of AMI ( ST ‐elevation myocardia...

2015 Journal of the American Heart Associa... 103 citations

Publication Info

Year: 2005
Type: article
Volume: 294
Issue: 10
Pages: 1224-1224
Citations: 714
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Effect of Clopidogrel Pretreatment Before Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolytics<SUBTITLE>The PCI-CLARITY Study</SUBTITLE>

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

714

OpenAlex

Cite This

APA Style

                            
                                
                                    Marc S. Sabatine, 
                                
                                    Christopher P. Cannon, 
                                
                                    C. Michael Gibson
                                
                                et al.
                            
                            (2005). 
                            Effect of Clopidogrel Pretreatment Before Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolytics&lt;SUBTITLE&gt;The PCI-CLARITY Study&lt;/SUBTITLE&gt;. 
                            JAMA
                            , 294
                            (10)
                            , 1224-1224.
                            https://doi.org/10.1001/jama.294.10.1224
                        

Identifiers

DOI: 10.1001/jama.294.10.1224